Esperion Therapeutics
ESPR
#7765
Rank
NZ$0.44 B
Marketcap
$2.27
Share price
-7.19%
Change (1 day)
-56.32%
Change (1 year)

Esperion Therapeutics (ESPR) - Total debt

Total debt on the balance sheet as of December 2024 : NZ$0.52 Billion

According to Esperion Therapeutics's latest financial reports the company's total debt is NZ$0.52 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Esperion Therapeutics - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.52 B25.38%
2023-12-31NZ$0.42 B2.4%
2022-12-31NZ$0.41 B7.89%
2021-12-31NZ$0.38 B48.25%
2020-12-31NZ$0.25 B10972.16%
2019-12-31NZ$2.32 M
2018-12-31N/A-100%
2017-12-31NZ$1.47 M-62.68%
2016-12-31NZ$3.94 M-37.13%
2015-12-31NZ$6.27 M0.91%
2014-12-31NZ$6.21 M
2012-12-31NZ$27.67 M213.2%
2011-12-31NZ$8.83 M
2002-12-31NZ$16.79 M9.94%
2001-12-31NZ$15.27 M81.83%
2000-12-31NZ$8.4 M58.03%
1999-12-31NZ$5.31 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$70.84 M-86.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.05 B 102.52%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$111.78 B 21,287.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.74 B 808.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.77 B 49.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.19 B-63.58%๐Ÿ‡บ๐Ÿ‡ธ USA